Press Release: Altravax : New Market Report: AltraVax Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

(PR-inside.com) AltraVax Inc. (Altravax) is a biopharmaceutical company. The company discovers and develops vaccines for the prevention and treatment of infectious diseases and other related conditions. It offers therapeutic vaccine for chronic hepatitis B virus infection and dengue. Altravax develops hepatitis B therapeutics using immunogen optimization system technology. The company offers vaccine for dengue viruses such as DENV 1, DENV 2, DENV 3, and DENV 4. Its dengue vaccine candidate is based on a VLP platform and has demonstrated immunogenicity in non-human primates. The company has its presence in North Dakota and California. Altravax is headquartered in Fargo, North Dakota, the ..